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Cyclic AMP (cAMP) inducible transcription factor cAMP responsive element binding
protein 3 like 1 (Creb3l1) is strongly activated in the hypothalamus in response
to hyperosmotic cues such as dehydration (DH). We have recently shown that
Creb3l1 expression is upregulated by cAMP pathways in vitro, however the exact
mechanisms are not known. Here we show that increasing Creb3l1 transcription by
raising cAMP levels in mouse pituitary AtT20 cells automatically initiates cleavage
of Creb3l1, leading to a greater abundance of the transcriptionally active N-terminal
portion. Inhibiting protein synthesis indicated that de novo protein synthesis of an
intermediary transcription factor was required for Creb3l1 induction. Strategic mining
of our microarray data from dehydrated rodent hypothalamus revealed four candidates,
reduced to two by analysis of acute hyperosmotic-induced transcriptional activation
profiles in the hypothalamus, and one, orphan nuclear receptor Nr4a1, by direct shRNA
mediated silencing in AtT20 cells. We show that activation of Creb3l1 transcription by
Nr4a1 involves interaction with a single NBRE site in the promoter region. The ability
to activate Creb3l1 transcription by this pathway in vitro is dictated by the level of
methylation of a CpG island within the proximal promoter/5′UTR of this gene. We thus
identify a novel cAMP-Nr4a1-Creb3l1 transcriptional pathway in AtT20 cells and also,
our evidence would suggest, in the hypothalamus.
Keywords: vasopressin, cAMP, transcription factors, transcriptional activation, hypothalamus, methylation
INTRODUCTION
Transcription factor cAMP responsive element binding protein 3 like 1 (Creb3l1), also known
as old astrocyte specifically-induced substance (OASIS), was first identified in long-term
cultured astrocytes and gliotic tissue (Honma et al., 1999). Creb3l1 is one of five members
of the Creb3 basic leucine zipper domain transcription factor subfamily (Kondo et al., 2011).
The Creb3 subfamily of transcription factors are structurally similar to activating transcription
factor 6, a classical endoplasmic reticulum (ER) stress transducer, but are activated by a diverse
range of stimuli in a cell-type specific manner (Chan et al., 2011). Upon stimulation, full-length
Creb3l1 protein is cleaved by regulated intramembrane proteolysis (RIP), first by site-1-protease
(S1P), giving rise to an intermediate cleavage product, followed by site-2-protease (S2P) cleavage
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to liberate the N-terminal fragment (Murakami et al., 2006).
This active form of Creb3l1 enters the nucleus to activate the
transcription of target genes (Omori et al., 2002). Whilst it is
well accepted that activation of Creb3l1, like other Creb3 family
members, requires RIP (Chan et al., 2011), the mechanisms that
mediate the physiological regulation of Creb3l1 are less well
understood.
One of the well-documented mechanisms of activating
Creb3l1 is by ER stress. Inducing ER stress with tunicamycin or
thapsigargin has been shown to activate Creb3l1 RIP (Murakami
et al., 2006; Vellanki et al., 2010, 2013). Triggering ER stress
also enhances Creb3l1 protein stability in cultured cells (Kondo
et al., 2012). In C6 glioma cells and cultured astrocytes, early
studies showed that Creb3l1 was involved in the unfolded protein
response (UPR), identifying ER chaperone protein 78-kDa
glucose-regulated protein (Grp78) as a target of Creb3l1 effects
(Murakami et al., 2006). That said, a separate study on the
involvement of Creb3l1 in the UPR response in pancreatic beta
cells showed that the expression of Grp78 and other UPR target
genes expression was not affected (Vellanki et al., 2010). Indeed,
it is becoming clear that Creb3l1 has more diverse functions than
simply ER stress, with reports of an involvement in secretion,
hormone synthesis, the formation of the extracellular matrix and
cellular proliferation (Fox and Andrew, 2015). This is backed up
by recent reports of activation of Creb3l1 in vitro by hypoxia,
cytokines and progesterone, suggesting that ER stress is but one
of many mechanisms through which the Creb3l1 protein can
be activated (Chen et al., 2014; Cui et al., 2015; Ahn et al.,
2016).
We recently identified Creb3l1 as a transcription factor of
the arginine vasopressin (Avp) gene in magnocellular neurones
of the paraventricular nucleus (PVN) and supraoptic nucleus
(SON) of the hypothalamus (Greenwood et al., 2014). The rise
in plasma osmolality that follows dehydration (DH; complete
fluid deprivation) or salt loading (SL; obligate consumption
of a 2% w/v NaCl drinking diet) strongly upregulates
Creb3l1 expression in vasopressinergic magnocellular neurones
in the SON and PVN, with a corresponding increase in
the protein abundance. In a later study we used this
physiological model to investigate Creb3l1 actions on UPR
pathways in these neurones (Greenwood et al., 2015b). Whilst
physiological stimuli increased expression of some ER stress
genes in parallel with Creb3l1, viral-manipulation of endogenous
Creb3l1 action by overexpression of a dominant negative mutant
of Creb3l1 in the brain did not alter classical UPR output,
suggesting that increased expression of Creb3l1 in vitro is not
associated with the induction of UPR target genes in these
neurones.
Whilst many investigators have focused on mechanisms
regulating RIP (Omori et al., 2002; Murakami et al., 2009; Denard
et al., 2011; Chen et al., 2014), few have sought to uncover the
signaling mechanisms regulating Creb3l1 at the transcriptional
level.We have recently reported that endogenous Creb3l1mRNA
expression and cleavage of full-length Creb3l1 are both robustly
increased by cyclic AMP (cAMP) pathways in pituitary
corticotroph AtT20 cells (Greenwood et al., 2015a), hinting
that increased Creb3l1 transcription and cleavage go hand in
hand. It is known that cAMP levels increase in the SON in
response to hyperosmotic stress (Carter and Murphy, 1989)
wherein Creb3l1 mRNA abundance and liberation of N-terminal
Creb3l1 also increase (Greenwood et al., 2014) resulting
in increased Avp transcription, however the involvement of
cAMP pathways in upregulating Creb3l1 expression are not
understood.
We have addressed these questions in this study by
asking, first, what is the major signaling pathway activating
Creb3l1 transcription and, second, what gene products
are responsible? Our data describes a novel model of
Creb3l1 transcriptional activation by orphan nuclear receptor
subfamily 4 group A member 1 (Nr4a1, aka TR3, Nur77) that
is affected by Creb3l1 promoter methylation status. We have
investigated signalingmechanisms regulating Creb3l1 expression
using in vitro cell cultures and translated our findings to
neurones of the rat hypothalamus. This study identifies Nr4a1 as
a putative transcriptional regulator of the Creb3l1 gene.
MATERIALS AND METHODS
Animals
Male Sprague-Dawley rats (purchased from Harlan) weighing
250–300 g were used in this study. Rats were maintained under
a 14:10 light dark cycle. Animal experiments were performed
between 9 am and 2 pm. We used two protocols a chronic
and an acute hypertonic stress protocol. To induce chronic
hyperosmotic stress, water was removed (DH) for 3 days or
replaced by 2% (w/v) NaCl in drinking water for 7 days SL.
The control group had access to food and water ad libitum.
The acute responses were assessed (10 and 30 min, 1, 2, or
4 h) after a single intraperitoneal injection of hypertonic saline
(1.5 ml/100 g body weight of 1.5 M NaCl solution). After
injection, hypertonic saline rats were placed back in their home
cages and water was removed. The reference group (time 0) had
access to food and water ad libitum. The study was carried out
under a Home Office UK licence (PPL 30/3278) held under,
and in strict accordance with, the provision of the UK Animals
(Scientific Procedures) Act (1986). The protocols were approved
by the University of Bristol Animal Welfare and Ethical Review
Board.
Cells and Treatments
Mouse pituitary cell line AtT20/D16v-F2 (Sigma; 94050406),
Human Embryonic Kidney cells HEK293T/17 (ATTC CRL-
11268), Neuro 2a cells N2a (ATTC CCL-131) and breast
cancer cell line Mcf-7 (a kind gift from Dr. Stephen Lolait,
University of Bristol) were cultured in DMEM (Sigma;
D6546) supplemented with 10% (v/v) heat-inactivated
fetal bovine serum (Gibco), 2 mM L-glutamine (Gibco)
and 100 unit/ml of penicillin-streptomycin (Gibco).
Cells were incubated at 37◦C in a humidified incubator
with 5% (v/v) CO2. For chemical treatments, cells were
seeded onto tissue culture plates to 60%–70% confluence.
Transfections were performed using Lipofectamine LTX
transfection reagent (Thermo Fisher Scientific, Waltham,
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MA, USA). Chemical treatments were performed at the
time points indicated in the figure; 10 µM forskolin
(FSK; Sigma), 100 nM dexamethasone (Sigma), 100 µg/ml
cycloheximide (CHX; Clontech), 10 µM SB202190 (Sigma),
10 µM H89 (Abcam), 10 µM U0126 (Cell Signaling
Technology, Danvers, MA, USA) and 2.5–10 µM 5-Aza-
2′deoxycytidine (Sigma). Stock solutions were prepared in
DMSO.
To produce knockdown cell lines, cells were transduced
with a lentivirus containing shRNAs targeting c-Fos or Nr4a1.
The shRNA sequences (mouse c-Fos shRNA GCTGAAGGCA
GAACCCTTTGA, Rat Nr4a1 shRNA1 CAAGTACATCTGC
CTGGCAAA and shRNA2 GCCAGACTTATGAAGGCCTCT,
human Nr4a1 shRNA GCTACACAGGAGAGTTTGACA) were
obtained from the RNAi consortium shRNA library. Sense
and antisense oligonucleotides for shRNAs were annealed and
ligated into lentiviral transfer vector pLKO.1 puro according
to manufacturer’s guidelines (pLKO.1 puro was a gift from
Bob Weinberg, Addgene plasmid 8453). A non-targeting (NT)
shRNA sequence (ATCATGTTAGGCGTACGGACT) was used
as a control. Virus particles were produced in HEK293T/17 cells
as previously described (Greenwood et al., 2014). Twenty-four
hours after transduction, culture media was replaced with fresh
media containing puromycin (2µg/ml, Thermo Fisher Scientific,
Waltham, MA, USA). The transduced cells were subcultured
in the presence of puromycin for 2 weeks before use in
experiments where puromycin was removed from the culture
media.
Quantitative Real-Time PCR Analysis
The protocols from RNA extraction and cDNA synthesis
from brain punches and cells has previously been described
(Greenwood et al., 2016b). qRT-PCRs were carried out in
duplicate using SYBR green (Roche) on an ABI StepOnePlus
Sequence Detection System (ABI, Warrington, UK). For
relative quantification of gene expression the 2−∆∆CT method
was employed (Livak and Schmittgen, 2001). The internal
control gene used for these analyses were the housekeeping
gene Rpl19 and Gapdh. Primers for rat Creb3l1 (5′-
GAGACCTGGCCAGAGGATAC-3′ and 5′-GTCAGTGA
GCAAGAGAACGC-3′), mouse Creb3l1 (5′-ACAAACTGCA
GGGGACATCA-3′ and 5′-GAGCTTGGTGGGGATAGGG-3′),
human Creb3l1 (5′-GCAGCCTTGTGCTTTGTTCT-3′ and
5′-GGGGGTCTTCCTTCACAGTC-3′), mouse c-Fos (5′-TC
CCCAAACTTCGACCATGA-3′ and 5′-GGCTGGGGAATG
GTAGTAGG-3′), rat Fos like antigen 1 (Fosl1) (5′-TCCA
GGACCCGTACTTGAAC-3′ and 5′-CTGCTGCTGCTAC
TCTTTCG-3′), rat CCAAT enhancer binding protein beta
(Cebpb) (5′-CAAGCTGAGCGACGAGTACA-3′ and 5′- CA
GCTGCTCCACCTTCTTCT-3′), rat Nr4a1 (5′-GCACAGC
TTGGGTGTTGATGT-3′ and 5′-GAGGCCATGTCGATC
AGTGAT-3′), mouse Nr4a1 (5′- GCACAGCTTGGGTGTT
GATGT-3′ and 5′-GAGCCCGTGTCGATCAGTGAT-3′),
human Nr4a1 (5′-GGCAAGCTCATCTTCTGCTC-3′ and
5′-CAGGGACATCGACAAGCAAG-3′), rat heteronuclear Avp
(hnAvp) (5′-GAGGCAAGAGGGCCACATC-3′ and 5′-CTCT
CCTAGCCCATGACCCTT-3′), rat mature Avp (5′-TGCC
TGCTACTTCCAGAACTGC-3′ and 5′-AGGGGAGACACT
GTCTCAGCTC-3′), mouse mature Avp (5′-GAGTGCCACG
ACGGTTT-3′ and 5′-AGCTGTACCAGCCTTAGC-3′), rat
heteronuclear oxytocin (hnOt) (5′-TGAGCAGGAGGGGGCCT
AGC-3′ and 5′-TGCAAGAGAAATGGGTCAGTGGC-3′), rat
mature Ot (5′-TGCCCCAGTCTTGCTTGCT-3′ and 5′-TCC
AGGTCTAGCGCAGCCC-3′), rat Rpl19 (5′-GCGTCTGCA
GCCATGAGTA-3′ and 5′-TGGCATTGGCGATTTCGTTG-
3′), mouse Gapdh (5′-CAACTCCCACTCTTCCACCT-3′ and
5′-CTTGCTCAGTGTCCTTGCTG-3′) and human Gapdh
(5′-AATCCCATCACCATCTTCCA-3′ and 5′-TGGACTCCA
CGACGTACTCA-3′) were synthesized by Eurofins MWG
Operon.
Western Blotting
The protocols for extraction of proteins from tissues punches
and cells for immunoblotting have previously been described
(Greenwood M. P. et al., 2015). Primary antibodies used were
goat polyclonal anti-Creb3l1 (1:1000; R&D Systems, AF4080),
mouse anti-GAPDH (1:10,000; Santa Cruz, sc-32233), rabbit
anti-HA tag (1:10,000, Abcam, ab9110) and mouse anti-Flag
(1:2000, Sigma, F1804).
Immunofluorescent Staining
The protocol for collection and staining of rat brain sections
and cultured cells has previously been described (Greenwood
et al., 2016b). The fluorescent images were captured using
a Leica DMRB microscope with Leica DFC340FX camera
using LAS software. Confocal images were obtained using
a Leica SP5-II confocal laser scanning microscope attached
to a Leica DMI 6000 inverted epifluorescence microscope
using LAS software. Primary antibodies were as follows; goat
polyclonal anti-Creb3l1 (1:500), mouse anti-cAMP antibody
(1:1000; Abcam, ab24851), rabbit polyclonal anti-Nr4a1 (1:50;
Santa Cruz, sc-7978), rabbit polyclonal anti-c-Fos (1:25,000;
Millipore, PC38) and rabbit anti-HA tag antibody (1:10,000).
We have previously described the specificity of the Creb3l1 for
Western blotting and immunofluorescent staining applications
(Greenwood et al., 2014, 2015a, 2016b).
Luciferase Assay
For luciferase assays, Creb3l1 promoter fragments were
cloned into luciferase reporter construct pGL3 basic vector
(Promega, Madison, WI, USA). Initially a 3 kb fragment
of the rat Creb3l1 promoter was amplified (5′-CTAGCT
AGCATCCCACTGCCCCATCCTGT-3′ and CCGCTCGAGT
CACTTTCCGGAGTCTGAAACC) from rat liver genomic
DNA template and ligated into the KpnI and XhoI sites
of pGL3. This promoter construct was extended by 2 kb
by amplification (5′-CGGGGTACCTTGAGAGATGAAGC
TGAGCGGTGTG-3′ and 5′-TTCTAGTTCCGGTACCTCC
TGTGCAGTCT-3′) of a more distal 5′ promoter region
and cloned into the pGL3 KpnI site and Creb3l1 promoter
KpnI cut site. A series of smaller rat Creb3l1 luciferase
reporter constructs were made by restriction enzyme
digestion (BamHI, BstEII, SacI, StuI) at sites present in
the Creb3l1 promoter, blunted (with exception of StuI)
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with T4 DNA polymerase and excised from pGL3 with
XhoI. The excised fragments were cloned into the SmaI
and Xho1 sites of pGL3. Deletion mutants (-NBRE2 and
-NBRE3) of the rat Creb3l1 promoter were generated by
overlap extension PCR using Phusion High-Fidelity DNA
Polymerase (New England BioLabs, Ipswich, MA, USA).
The first round of PCRs were performed using primers
(-NBRE2 set 1 5′-TGCAAGCAAACAAGGCAGGTTTA
CTTTGGGCCCACCACCACCCGGGGCCTG-3′ and 5′-
TTCTAGTTCCGGTACCTCCTGTGCAGTCT-3′ and set 2
5′-CGGGGTACCTTGAGAGATGAAGCTGAGCGGTGT
G-3′ and 5′-CCCAAAGTAAACCTGCCTTGTTTGCTTGCA-
3′; -NBRE3 5′-TGCATCCCAGCAAGAGCCTCACTCTTC
GCCCAGGTCCCGGACAGACAGAGG-3′ and 5′-TTCTAGT
TCCGGTACCTCCTGTGCAGTCT-3′ and set 2 5′-CGGG
GTACCTTGAGAGATGAAGCTGAGCGGTGTG-3′ and
5′-GGCGAAGAGTGAGGCTCTTGCTGGGATGCA-3′).
The PCR products from the initial PCRs were combined
and used as a template for a subsequent PCR using primers
5′-CGGGGTACCTTGAGAGATGAAGCTGAGCGGTGTG-
3′ and 5′-TTCTAGTTCCGGTACCTCCTGTGCAGTCT-
3′. The site-directed deletions (-NBRE2 and -NBRE3)
were ligated into Kpn1 digested 4.9 kb Creb3l1 promoter
pGL3 construct.
In vitro methylation of the Creb3l1 promoter plasmid
DNA was performed using SssI methylase according to the
manufacturer’s instructions (New England Biolabs, Ipswich,MA,
USA). Control reactions were performed by omitting the enzyme
from the reaction mixture.
Luciferase assays were performed as described previously
(Greenwood et al., 2014). Plasmid constructs (0.1 µg
pGL3-Creb3l1 promoter + 0.4 µg pcDNA3-Nr4a1) for
co-transfection studies or 0.5 µg pGL3-Creb3l1 for chemical
treatments, together with 1 ng control renilla reporter
pRL-CMV (Promega, Madison, WI, USA) vector/well. The
pRL-TK renilla reporter plasmid has previously been shown
to be activated by Nr4a1 (Shifera and Hardin, 2010). In
the present study pRL-SV40 and pRL-TK renilla reporter
plasmids were both activated by Nr4a1 overexpression
in AtT20 cells so were not suitable control reporter
vectors.
Chromatin Immunoprecipitation (ChIP)
Cells were seeded (5 × 106) in to 10 cm tissue culture
plates. The following day cells were transfected with either
10 µg HA-Nr4a1 or 10 µg Nr4a1 and collected 48 h
later. ChIP assays were performed using the Zymo-Spin
ChIP Kit (Cambridge Bioscience) with the following
modifications. Chromatin shearing was performed by
sonication (4 cycles of 30 s on ice) using a MSE Soniprep
150 probe sonicator. Immunoprecipitations were performed
with 10 µg of sheared chromatin as input and 1 µg of
rabbit anti-HA tag antibody (Abcam, ab9110) at 4◦C
overnight with rotation. The complexes were captured with
15 µl of Dynabeads Protein G (Thermo Fisher Scientific,
Waltham, MA, USA). The ChIP enrichment for the mouse
Creb3l1 promoter DNA was determined by RT-PCR
using primers NBRE2 (5′-CATTCCCCACAAGTTCCTGC-
3′ and 5′-TGTTTGCCTGCCTCGTAAAG-3′) and
NBRE3 (5′-TGACTCTCCACCTGACCTTC-3′ and 5′-
TCAGTGACGCACAGGAAGAA-3′).
Dual DNA and RNA Extraction from AVP
and OT PVN Punch Samples
Frozen brains were sliced into 60 µm coronal sections in
a cryostat set at −20◦C. When slices approached the PVN,
individual sections were mounted on glass slides and stained
with 0.1% (w/v) toluidine blue then visualized on a light
microscope until neurones of this brain nucleus were visible.
A 27 gauge needle was then used to create small tracts lateral
to the posterior magnocellular subdivision of the PVN in
the frozen brain tissue in the cryostat sample holder. Then
brains were sectioned further, mapping each section, until
subdivisions of the PVN were visible. A micropunch (Fine
Scientific Tools) with an inner diameter of 0.35 mm was
used to collect the posterior magnocellular subdivision of
the PVN using the 3rd ventricle and needle tracts from the
preceding section as reference points in order to improve the
punching accuracy from frozen brain slices. A second more
medial 0.35 mm punch was collected from the same side of
the PVN and placed into a separate tube. The punches were
collected bilaterally from three brain slices and dispensed into
0.5 ml tubes (six punches per tube) placed on dry ice within
the cryostat. Total RNA and genomic DNA were extracted
from each sample as previously described (Greenwood et al.,
2016a).
Bisulfite Conversion and Sequencing
Genomic DNA from AVP and OT PVN punches (whole
sample) and cultured cells (200 ng) was bisulfite converted
using Zymo EZ DNA Methylation-Gold kit (Cambridge
Bioscience) as previously described (Greenwood et al.,
2016a). Primers for amplification of bisulfite converted
DNA were designed using MethPrimer software;
(mouse 5′-TTAGAGAGTTGAGTTAGTTAAGGAAA-
3′ and 5′-CAAAAATCTCTCTAAATCTCTTCC-3′;
rat 5′-AGGAAGTTTATAGTTTTTAGGATAG-3′ and
5′-AAAAATCTCTCTAAATCTCTTCCTC-3′; human
5′-TTGGAAGGATGGAAATAGTTTT-3′ and 5′-
AAACCCCTAACTAACTAACCCAACTA-3′). The converted
DNA was amplified using Platinum Taq DNA Polymerase
(Thermo Fisher Scientific, Waltham, MA, USA) with the
following cycling parameters: 94◦C for 2 min followed by
45 cycles of 94◦C for 30 s, 50◦C for 30 s and 72◦C for 2 min. The
PCR products were purified using Qiagen’s PCR purification
kit and ligated into pGEM-T Easy vector (Promega, Madison,
WI, USA). Ten independent clones were sequenced per
sample.
RNA Scope Protocol
Frozen brains were sliced into 16 µm coronal sections in
a cryostat. Sections were individually mounted on Superfrost
Plus slides (Thermo Fisher Scientific, Waltham, MA, USA) and
stored in slide boxes at −80◦C. Tissue was fixed in ice-cold
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4% paraformaldehyde for 15 min, followed by 2 × 5 min in
phosphate buffered saline washes, and dehydrated by passage
through a grade series of ethanol washes (50%–100%) for 5 min
each. The brain sections were encircled on the slides using an
ImmEdge pen (Vector Laboratories) to create a hydrophobic
barrier. The tissue was treated with 100 µl RNAscope protease
reagent (Advanced Cell Diagnostics, Newark, CA, USA) for
30 min at room temperature and washed 2 × 2 min in water. A
multiplex RNAscope assay was performed using the RNAscope
Multiplex Fluorescent Reagent Kit (Advanced Cell Diagnostics,
320850) in accordance with the manufacturer’s guidelines.
The RNAscope probes were designed and/or purchased from
Advanced Cell Diagnostics. The Rn-AVP probe (Cat No PN
401421) was purchased in channel C2 while a 4ZZ probe
targeting bases 2–490 of rat Ot was designed and manufactured
by Advanced Cell Diagnostics. All incubations were performed
in a HybEZ oven (Advanced Cell Diagnostics, Newark, CA,
USA).
Statistical Analysis
Statistical differences between two experimental groups were
evaluated using independent-sample unpaired Student’s t tests.
One-way ANOVA with Tukey’s post hoc test were used to
determine the difference between more than two samples
with only a single influencing factor. Two-way ANOVA with
Bonferroni post hoc test was used to determine interactions
between two independent variables on the dependent variable.
RESULTS
The Rate-Limiting Step in the Generation
of Active Creb3l1 Is Transcription
We have previously shown that Creb3l1 expression is increased
by cAMP pathways using in vitro cell cultures and in ex vivo
hypothalamic cultures (Greenwood et al., 2015a). Using a specific
antibody, we identified increased cAMP levels in magnocellular
neurones of the PVN and SON with osmotic stress, in parallel,
and consistent with an increase of Creb3l1 protein expression
(Figure 1A). Immunoblot analysis of protein extracts from
punches of the PVN and SON revealed an increase in full-length
and cleaved forms of Creb3l1 as a consequence of DH and SL
(Figure 1B). These changes occur in parallel with an increase
in the abundance of Creb3l1 mRNA in both PVN and SON
of 3 days dehydrated rats (Figure 1C). To determine any
relationship between Creb3l1 expression and restrictions of
RIP, we conducted densitometric analysis of full-length and
cleaved Creb3l1 bands in FSK treated AtT20 cells (Figure 1D).
We found that both full-length and cleaved Creb3l1 protein
forms increase by equivalent levels, and the ratio of full-
length—cleaved Creb3l1 protein is not significantly altered
(Figure 1E). Therefore, the rate of cleavage would appear to
increase with increasing Creb3l1 mRNA abundance (Figure 1F).
These data argue against there being any mechanism eliciting
stimulus dependent regulation of RIP. In agreement, the ratio of
full-length Creb3l1 protein to intermediate and active N-terminal
forms persists in AtT20 transfected to over-express Creb3l1,
despite the high Creb3l1 protein loads placed on RIP system and
in the absence of any stimuli (Figure 1G).
Identification of Transcriptional Regulators
of Creb3l1
We treated AtT20 cells with signal pathway specific inhibitors
to investigate different routes of Creb3l1 transcriptional
activation initiated by cAMP pathways (Figure 2A).
Transcript levels of Creb3l1 decreased most markedly
following treatment with dexamethasone and p38 inhibitor
SB202190 in basal and FSK-stimulated states (Figure 2A).
To test if cAMP directly activates Creb3l1 transcription,
or if an intermediary step requiring protein synthesis was
necessary, we performed studies with the protein synthesis
inhibitor CHX. Using cells pretreated with CHX, we asked if
cAMP pathways could directly increase Creb3l1 expression
(Figure 2B). Inhibition of protein synthesis attenuated
FSK-induced Creb3l1 expression, suggesting that de novo
protein synthesis was necessary for up-regulation of
Creb3l1 expression.
We reasoned that the mRNA encoding this intermediate
protein must be increased in expression in the SON following
DH. We thus mined our previously published microarray
data of the dehydrated mouse and rat SON (Hindmarch
et al., 2006; Stewart et al., 2011) and, by performing cross-
species comparisons, narrowed our list of candidates to four
transcription factors (Figure 2C)—c-Fos, Fosl1, Nr4a1 and
Cebpb. We have previously described that activation profile of
c-Fos and Creb3l1 in the same samples of chronic and acute
hyperosmotic stress (Greenwood et al., 2015a). The expression
of Fosl1, Nr4a1 and Cebpb were also robustly increased in
SON and PVN of the rat by DH and SL, consistent with
our array data (Figure 2C). Using our acute hyperosmotic
stress protocol we observed markedly different transcriptional
activation profiles for these three genes (Figure 2D). We
previously showed in these samples that Creb3l1 mRNA
increases as early as 1 h after hypertonic saline injection in
the hypothalamus (Greenwood et al., 2015a) so allowing for
protein synthesis only c-Fos and Nr4a1 were deemed to be
viable candidates. These two transcription factors are already
well-known to be activated by cAMP pathways (Fass et al.,
2003).
Identification of Nr4a1 as a Novel
Regulator of the Creb3l1 Gene
Immunofluorescent staining showed that Creb3l1 expressing
magnocellular neurones also express c-Fos and Nr4a1,
particularly in animals that have been dehydrated for
3 days (Figure 3A). Therefore, we further assessed our
two candidates in relation to Creb3l1 expression in our
AtT20 cell model. To directly assess any roles of c-Fos and
Nr4a1 on Creb3l1 expression, we prepared knock down
cell-lines of c-Fos and Nr4a1 in AtT20 using lentiviral
vectors, and assessed basal (Figure 3B) and FSK stimulated
expression levels (Figure 3C). Knockdown of Nr4a1 with two
separate shRNAs significantly reduced basal and stimulated
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FIGURE 1 | Upregulation of cAMP responsive element binding protein 3-like 1 (Creb3l1) expression by cyclic AMP (cAMP) pathway. (A) Immunofluorescent staining
in paraventricular nucleus (PVN) and supraoptic nucleus (SON) of euhydrated and 3 days dehydrated rat. (B) Immunoblot analysis of total protein extracts from PVN
and SON of euhydrated, 3 days dehydrated and 7 days salt loaded rats. (C) qRT-PCR analysis of Creb3l1 in PVN and SON of euhydrated and 3 days dehydrated
rat. (D) Expression of full-length and cleaved Creb3l1 protein in response to forskolin (FSK) treatment. (E) Detection of full-length and cleaved Creb3l1 protein forms
in AtT20 cells 48 h after transfection with Flag-Creb3l1 construct. Densitometry analysis was performed by using Quantity One imaging software (Bio-Rad).
(F) Upregulation of Creb3l1 mRNA by foskolin in AtT20 cells determined by qRT-PCR. (G) Immunoblot showing Creb3l1 cleavage products in AtT20 cells
overexpressing N-terminal Flag tagged Creb3l1 construct. In (B) ∗ indicates the detection of non-specific bands by the Creb3l1 antibody in brain samples. DH,
dehydration; SL, salt loading; M, molecular weight marker. Values are means + SEM of n = 3−4 per group. ∗∗p < 0.01, ∗∗∗p < 0.001. Scale bars = 100 µm.
Creb3l1 mRNA and protein expression, whereas knockdown of
c-Fos did not (Figures 3B–D). Treatment of AtT20 cells with
p38 inhibitor also decreased FSK upregulation of Nr4a1 and
Creb3l1 mRNA expression, consistent with our earlier data
suggesting that this pathway regulates Creb3l1 expression
(Figure 3E).
Nr4a1 Regulates Creb3l1 Transcription by
Binding at the Promoter
To investigate Nr4a1 actions on the Creb3l1 promoter,
luciferase reporter assays were performed in AtT20 cells and
neuronal cell line N2a. Sequence analysis of 4.9 kb segment
of DNA upstream of the transcriptional start site of the rat
Creb3l1 gene revealed potential Nr4a1 binding motifs in the
Creb3l1 promoter region (Figure 4A). These included NurRE
half sites and NBRE forward and reverse motifs (Figure 4B).
We first validated the 4.9 kb luciferase reporter construct
by treating transfected cells with FSK, dexamethasone and
p38 inhibitor (Figure 4C). Treatment of cells with FSK
robustly increased luciferase activity in both cell lines consistent
with activation of Creb3l1 expression by cAMP pathways.
FSK-induced increases in Creb3l1 promoter activity were
attenuated by dexamethasone. However, treatment with the
p38 inhibitor SB202190 decreased promoter activity only in
AtT20 cells.
To identify Nr4a1 interaction sites in the Creb3l1 promoter-
luciferase assays were performed on a series of promoter
deletion constructs. Overexpression of Nr4a1 as well as FSK
treatment robustly increased activity of the 4.9 kb promoter
construct in both cell-types (Figure 4D). Truncation of the
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FIGURE 2 | Regulation of Creb3l1 expression. (A) AtT20 cells were pretreated with signaling pathway inhibitors for 24 h before treatment with vehicle (DMSO) or
stimulation with FSK (10 µM) for 6 h. The expression of Creb3l1 was evaluated by qRT-PCR. (B) AtT20 cells were pretreated with CHX or vehicle for 2 h followed by
FSK addition to culture media for up to 8 h and Creb3l1 mRNA expression was investigated by qRT-PCR. (C) Transcription factors mined from microarray data that
increase by greater than two-fold in the SON of the dehydrated mouse (2 days) and rat (3 days) compared to euhydrated controls. (D) Relative mRNA expression
was investigated by qRT-PCR in PVN and SON of euhydrated, dehydrated (3 days) and salt loaded (7 days) rats and after a single intraperitoneal injection of
1.5 ml/100 g body weight 1.5 M NaCl solution over a 4 h experimental period compared to controls. DH, dehydration; SL, salt loading; CHX, cycloheximide. Values
are means + SEM of n = 5–6 per group (animal) n = 3 per group (cell). ##p < 0.01 (t-test). ∗∗p < 0.01, ∗∗∗p < 0.001.
Creb3l1 promoter from 4.9 kb–3 kb greatly diminished promotor
activation by FSK and Nr4a1, more so in AtT20 cells
than N2a cells. Thus, indicating that the primary site for
activation by cAMP pathways and Nr4a1 is located within this
1.9 kb segment of DNA which contains NBRE and NurRE
responsive elements. Further deletions by restriction digests
of the promoter region narrowed the search to a 0.6 kb
section of DNA situated between 3.0 kb and 3.6 kb, which
contains a single NBRE site, NBRE3 (Figure 4E). Accordingly,
specific deletion mutants for NBRE3 and also NBRE2 were
generated. Deletion of NBRE3, but not NBRE2, profoundly
attenuated FSK and Nr4a1 activation of the Creb3l1 promoter
in AtT20 and N2a cells (Figure 4F). In AtT20 cells deletion of
NBRE3 completely abolished activation of the Creb3l1 promoter
by Nr4a1 showing that this site is important for the actions of
Nr4a1.
To demonstrate direct binding of Nr4a1 to this promoter
region we performed ChIP assays in AtT20 and N2a cells.
We made a 3×HA tagged NR4a1 construct and verified
its expression by Western blot in AtT20 cells and cellular
localization of the expressed protein by immunofluorescence in
both AtT20 and N2a cells (Figure 5A). The strong localization of
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FIGURE 3 | Identification of Nr4a1 as a novel regulator of the Creb3l1 gene. (A) Immunofluorescent localization of Creb3l1 with Nr4a1 and c-Fos in magnocellular
neurones of euhydrated and 3 days dehydrated rat. (B) The effect of c-Fos and Nr4a1 knockdown on basal expression of Creb3l1 were examined by qRT-PCR
compared to a control NT shRNA cell line. (C) Responses of knockdown cell lines to 4 h time course of FSK treatment compared to a control NT shRNA cell line.
(D) Immunoblot analysis of Creb3l1 expression in Nr4a1 knockdown cell lines treated with FSK. (E) The effect of pretreatment (2 h) of p38 inhibitor SB202190 on
FSK-induced upregulation of Nr4a1 and Creb3l1 mRNA in AtT20 cells. NT, non-targeting; FSK, forskolin. Values are means + SEM of n = 3 per group. ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001.
Nr4a1 protein in the nucleus is consistent with it having a role
as a transcriptional regulator. In AtT20 cells, the Nr4a1 binding
DNA fragments were identified by PCR using specific mouse
Creb3l1 promoter primers. The correctly sized bands were
enriched in anti-HA tag immunopreciptated DNA from the
HA-Nr4a1 but not Nr4a1 transfected AtT20 cells, suggesting
binding of Nr4a1 to the Creb3l1 promoter in this region
(Figure 5B). There was no enrichment of immunopreciptated
DNA in ChIP experiments performed in N2a cells, suggesting
little or no binding to the Creb3l1 promoter in this cell line.
Epigenetic Silencing of the Creb3l Gene by
CpG Promoter Methylation Inhibits
Activation by Nr4a1
We next investigated Nr4a1 and Creb3l1 mRNA expression
in three different cell lines, AtT20, N2a and Mcf-7, to better
understand the relationship between the expression of these
genes. We chose Mcf-7 cells because they have previously
been reported to express Creb3l1 (Denard et al., 2012).
Our data showed high Creb3l1 expression in AtT20 cells,
moderate expression in Mcf-7 and low expression in N2a
cells (Figure 6A). In contrast, Nr4a1 was expressed at
near equivalent levels in in all three cell lines, suggesting
factors other than Nr4a1 were influencing the expression of
Creb3l1. Treatment with FSK increased Nr4a1 expression
in all three cell lines, but Creb3l1 expression increased in
only AtT20 and Mcf-7 cells (Figure 6B). Knockdown of
Nr4a1 expression by lentiviral delivery of specific shRNAs
targeting Nr4a1 decreased Creb3l1 expression in Mcf-7 and
N2a cells, and blunted the increase in Creb3l1 abundance in
Mcf-7 cells treated with FSK, similar to our earlier findings
in AtT20 cells (Figure 6C). We asked if methylation of the
Creb3l1 promoter could be responsible. Using Methyl Primer
Express Software we identified a single CpG island in the
proximal promoter/5′UTR region of rodent and human Creb3l1
(Figure 6D). Analysis of individual CpGs in the proximal
promoter region showed that this region was unmethylated in
AtT20 cells, moderately methylated in Mcf-7 cells and highly
methylated in N2a cells, consistent with high, moderate and
low expression of Creb3l1 mRNA in the respective cell lines
(Figure 6E). To see if methylation of the Creb3l1 promoter
could affect activation of Creb3l1 transcription specifically
by Nr4a1, we performed in vitro methylation studies in
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FIGURE 4 | Identification of Nr4a1 as a novel regulator of the Creb3l1 gene. (A) Schematic representation of potential Nr4a1 responsive elements in the rat
Creb3l1 promoter region. (B) Sequences of NurRE and NBRE sites in the rat Creb3l1 promoter. (C) Rat Creb3l1 promoter-luciferase reporter constructs with
chemical treatments (4 h) in AtT20 and N2a cells. (D,E) Luciferase assays using plasmids containing deletion constructs of the Creb3l1 promoter-luciferase reporter
together with overexpression of Nr4a1 or 4 h FSK treatment. (E) Restriction enzyme generated deletion mutants of the Creb3l1 promoter to pinpoint the interacting
site of Nr4a1 with the promoter. (F) Luciferase assays using Nr4a1 responsive element site-directed deletion constructs of the Creb3l1 promoter with overexpression
of Nr4a1 or 4 h FSK treatment. Veh, vehicle; FSK, forskolin; DH, dehydration. Values are means + SEM of n = 3−4 per group. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
AtT20 and N2a cells. In vitro methylation of Creb3l1 promoter-
luciferase constructs by CpG methyltransferase blocked
activation of the Creb3l1 promoter by overexpression of
Nr4a1 (Figure 6F). In contrast, demethylation of DNA by
treatment with 5-Aza-2′deoxycytidine dose dependently
increased endogenous Creb3l1 expression in Mcf-7 cells
and dramatically increased Creb3l1 expression in N2a cells
(Figure 6G). Moreover, treatment of AtT20 cells with this
chemical had no effect on Creb3l1 expression consist with the
absence of methylation marks on the Creb3l1 promoter in this
cell line. The expression of Nr4a1 was largely unaltered by
these treatments. To see if we could rescue cAMP inducibility
of Creb3l1, we treated cells with FSK in addition to 5-Aza-
2′deoxycytidine. Treatment of Mcf-7 and N2a cells with FSK
was able to further upregulate Creb3l1 expression (Figure 6H).
Therefore, methylation of the Creb3l1 promoter dictates
Creb3l1 mRNA abundance in these cell lines where Nr4a1 is
similarly expressed.
As Creb3l1 is known to be a putative transcription factor of
the Avp gene (Greenwood et al., 2014), we tested if demethylation
could induce Avp expression in N2a cells (Figure 6I). Treatment
with Aza alone increased Avp expression, and when combined
with FSK this increase in expression was markedly enhanced.
To demonstrate that increased Avp expression was not the
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FIGURE 5 | Nr4a1 regulates Creb3l1 transcription by binding at the promoter. (A) Validation of HA tagged Nr4a1 construct by immunoblot in AtT20 cells and
immunofluorescence in AtT20 and N2a cells. (B) ChIP assays were performed using antibody against HA tag in Nr4a1 and HA-Nr4a1 transfected cells. Two sets of
primers (arrow heads) were designed to amplify promoter regions close to NBRE2 and NBRE3 consensus sequences by RT-PCR. PCR products from the ChIP
assay were verified by gel electrophoresis. Scale bars = 10 µm.
result of demethylation of the Avp promoter as we have
previously reported (Greenwood et al., 2016a), we overexpressed
Creb3l1 in N2a cells and were able to successfully reproduce this
response. Therefore, methylation strongly influences the actions
of Nr4a1 as a transcriptional regulator of the Creb3l1 gene
in vitro.
Transcriptional Regulation of
Creb3l1 Expression in the Rat PVN
To place our in vitro cellular findings within the context of
the whole organism, we looked at the molecular mechanisms
that alter Creb3l1 expression in the PVN of control and
3 days dehydrated rats. We performed RNAscope to look at
the distribution of Avp and Ot mRNAs in the PVN and
SON of the rat hypothalamus (Figure 7A). The architecture
of the PVN enables the enrichment of AVP neurones using a
circular micropunch to collect AVP and OT enriched cellular
populations. We show using qPCR that this technique is able
to enrich for AVP and OT expressing cells in the PVN of
control and 3 days dehydrated rats (Figure 7B). We then asked
about Nr4a1 and Creb3l1 expression in these samples. There
was no difference in Nr4a1 expression in the basal euhydrated
condition. However, in response to DH, Nr4a1 expression was
significantly increased in AVP compared to OT punch samples
(Figure 7C). In agreement with the concept of Nr4a1 activating
Creb3l1 transcription, Creb3l1 expression was also higher in
AVP compared to OT punches in dehydrated rats. We next
asked if methylation of the Creb3l1 promoter could explain
the difference in Creb3l1 expression in AVP and OT punch
samples in basal and dehydrated states (Figure 7D). We show
the rat Creb3l1 promoter to be completely unmethylated in all
samples tested. Therefore, the absence of methylation marks
on the Creb3l1 promoter in the PVN allows for activation by
transcription factors such as Nr4a1 within this brain nuclei.
DISCUSSION
ER stress has been at the forefront of investigations surrounding
regulation of Creb3l1 synthesis and cleavage by RIP since this
mechanism was first identified in C6 glioma cells (Murakami
et al., 2006). Here, we show that Creb3l1 cleavage is constitutively
active (CA) in AtT20 cells, with increased Creb3l1 transcription
automatically leading to a greater abundance of N-terminal
cleaved Creb3l1. Hence, understanding the pathways regulating
the rate-limiting step of Creb3l1 transcription are pivotal to
understand the cellular mechanisms activating Creb3l1. Here we
identify orphan nuclear receptor Nr4a1 as a transcription factor
of the Creb3l1 gene in AtT20 cells and also demonstrate that
methylation is a major factor determining Creb3l1 expression
in vitro. We show that Creb3l1 transcription is activated by
this novel pathway in vitro and present compelling evidence
that this mechanism may regulate Creb3l1 expression in AVP
neurones of the rat hypothalamus in conditions of osmotic
stress.
When stimulated by FSK, both full-length and cleaved forms
of Creb3l1 protein rapidly accumulate in AtT20 cells. The
proportion of inactive to active forms of Creb3l1 remains
constant regardless of overall protein abundance, suggesting
that cleavage by S1P and S2P is not a rate-limiting step in
this process. Thus we proposed that transcriptional control
of Creb3l1 by cAMP pathways is a rate-limiting step in
the generation of active N-terminal Creb3l1. Two candidate
pathways were identified for regulation of cAMP induced
Creb3l1 expression, one inhibitory pathway regulated by the
glucocorticoid dexamethasone, and one stimulatory pathway
involving p38 MAP kinase. We have previously shown that
the corticosteroid medication dexamethasone inhibits basal and
FSK-induced Creb3l1 expression in AtT20 cells (Delidaki et al.,
2011; Greenwood et al., 2015a). Here we show that basal and
FSK-induced expression of Creb3l1 are also regulated by the
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FIGURE 6 | Epigenetic silencing of the Creb3l1 gene by CpG promoter methylation. (A) Expression of Creb3l1 and Nr4a1 in different mammalian cell lines presented
as CT value. (B) Time course of FSK treatment in three different cell lines. (C) The effect of Nr4a1 knockdown on Creb3l1 expression in Mcf-7 and N2a cells.
(D) Identification of a conserved CpG island in the human and rodent Creb3l1 promoters (4.9 kb). (E) Methylation status of the Creb3l1 promoter CpG island in three
different cell lines. (F) Luciferase assays of methylated Creb3l1 luciferase reporter constructs with overexpression of Nr4a1 or 4 h FSK treatment. (G) qRT-PCR
analysis of Creb3l1 and Nr4a1 in cell lines treated with doses of 2.5–10 µM of 5-Aza-2′deoxycytidine for 72 h. (H) FSK stimulation (4 h) of cells treated with
5-Aza-2′deoxycytidine (72 h, 5 µM). (I) The effect of 5-Aza-2′deoxycytidine and FSK treatment on expression of arginine vasopressin (Avp) in N2a cells. Increase of
Avp mRNA expression by overexpression of a constitutively active (CA) mutant of Creb3l1 in N2a cells. TSS, transcription start site. Values are means + SEM of
n = 3−4 per group. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
Frontiers in Molecular Neuroscience | www.frontiersin.org 11 December 2017 | Volume 10 | Article 413
Greenwood et al. Transcriptional Regulation of Creb3l1
FIGURE 7 | Transcriptional regulation of Creb3l1 expression in the rat PVN. (A) Fluorescent in situ hybridization marking the distribution of Avp and Ot mRNAs in the
SON and PVN. The toluidine blue stained section illustrates the punches collected for mRNA analysis. In the PVN the enrichment of AVP positive neurones in the
posterior magnocellular bundle (labeled AVP) and OT positive neurones more medially (labeled OT) enabled a level of separation of these subdivisions. A 27 gauge
needle was then used to create small tracts lateral to the posterior magnocellular subdivision of the PVN (labeled marker) for orientation of punching. (B) qRT-PCR
analysis of Avp and Ot RNAs in AVP and OT punches in the euhydrated and 3 days dehydrated rat PVN. (C) qRT-PCR analysis of Nr4a1 and Creb3l1 expression in
AVP and OT punches in the euhydrated and 3 days dehydrated rat PVN. (D) Methylation status of 12 CpGs on the Creb3l1 promoter in DNA extracted from AVP and
OT punch samples of euhydrated and dehydrated rat. DH, dehydration. Values are means + SEM of n = 4 per group. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. Scale
bars = 100 µm.
p38 MAPK kinase pathway in this cell line. Inhibition of
Creb3l1 expression by p38 inhibitors has been reported in human
placental cell-line BeWo suggesting that this signaling pathway is
not exclusive to our model (Delidaki et al., 2011).
We show that stimulation of Creb3l1 expression by FSK
is blunted in the presence of protein synthesis inhibitor
CHX. The need for de novo protein synthesis for cAMP
stimulation of Creb3l1 expression implied that intermediary
factor/s, also activated by cAMP pathways, are necessary for the
initiation of Creb3l1 transcription. By systematically eliminating
candidate transcriptional regulators of Creb3l1 sourced from
microarray data of the SON (Hindmarch et al., 2006), we
identified orphan nuclear receptor Nr4a1 as being important for
Creb3l1 transcription.
Nr4a1 is classified as an orphan because no endogenous ligand
has yet been identified. This receptor behaves as an immediate
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early gene, and as such, its mRNA is induced rapidly in response
to a stimulus, a process that occurs independently of protein
synthesis (Maruyama et al., 1995). The expression of Nr4a1 is
well-known for being activated by cAMP pathways (Maruyama
et al., 1995). Moreover, the regulation of Nr4a1 expression
has also been shown to involve the activation of p38 (Li
et al., 2015; Shao et al., 2016). The subcellular localization of
Nr4a1 is important for its function, and as such, an increase
in Nr4a1 expression is not necessary to increase its activity,
which can be achieved by posttranslational modifications such
as phosphorylation (Fahrner et al., 1990). In the nucleus,
Nr4a1 can act as a transcriptional modulator by binding as
a monomer, homodimer and heterodimer at specific DNA
responsive elements such as NurRE and NBRE (Philips et al.,
1997). We provide strong evidence that Nr4a1 interacts with the
Creb3l1 promoter at single NBRE site in its promoter to regulate
Creb3l1 transcription.
Nr4a1 has been reported to bind and activate transcription
of NurRE and NBRE reporter constructs, without requiring
any additional factors (Davis et al., 1991; Wilson et al.,
1991). This said, members the Nr4a receptor family have
been shown to interact with each other and a variety of
co-regulators for optimal gene regulation (Campos-Melo
et al., 2013). Nr4a1 and Nr4a2 can form heterodimers that
interact with NurRE sequences to enhance transcription of
reporters (Maira et al., 1999). Furthermore, Nr4a1 has also
been shown to form heterodimers with the retinoid × receptor,
receptors of 9-cis retinoic acid, which have roles in multiple
nuclear receptor signaling pathways (Morita et al., 2005).
Another binding partner of Nr4a1 is KRAB domain
association protein 1 (Kap1), which was first identified
as a co-activator of Nr4a1 transcription in AtT20 cells
(Rambaud et al., 2009). Nr4a2, Kap1 and retinoid × receptors
are expressed in the hypothalamus (Kawasaki et al., 2005;
Rambaud et al., 2009; Johnson et al., 2015). Therefore, these
Nr4a1 transcription factor complexes may be important in the
regulation of Creb3l1 expression, although this remains to be
established.
The identification of Nr4a1 as a transcription factor of
the Creb3l1 gene may have importance in cancer research.
The expression levels of Nr4a1 and Creb3l1 have been used
a biomarkers to grade cancerous cells/tumors (Alexopoulou
et al., 2010; Rose et al., 2014; Safe et al., 2014; Denard
et al., 2015; Ward et al., 2016). No connection has currently
been made between Nr4a1 and Creb3l1 expression in cancer
cells, but there are studies that support this concept. A study
FIGURE 8 | Modeling transcriptional control of the Avp gene in magnocellular neurones of the hypothalamus. cAMP levels increase in magnocellular neurons in
response to raised plasma osmolality resulting from DH. Our in vitro studies have indicated that p38 may increase Nr4a1 and also Creb3l1 mRNA expression but any
direct actions in vitro and in magnocellular neurones remain to be established (dotted lines). What is known is that Nr4a1 expression increases in AVP magnocellular
neurons alongside increased expression of Creb3l1 in the dehydrated rat. Due to an absence of methylation marks on the Creb3l1 promoter in vivo, Nr4a1 has the
capacity to increase Creb3l1 transcription through it interactions with a single NBRE site in the promoter resulting in increased full-length Creb3l1 protein. Inactive
Creb3l1 protein is anchored in the endoplasmic reticulum (ER) membrane. Upon stimulation by DH, Creb3l1 is transported to Golgi apparatus where it is activated by
regulated intramembrane proteolysis (RIP). The N-terminal active form of Creb3l1 then enters the nucleus to activate transcription of Avp.
Frontiers in Molecular Neuroscience | www.frontiersin.org 13 December 2017 | Volume 10 | Article 413
Greenwood et al. Transcriptional Regulation of Creb3l1
by Mellor et al. (2013) reported low Creb3l1 expression in
metastatic breast cancer cells lines compared to cell lines that
had little or no metastatic capabilities (Mellor et al., 2013). A
separate study investigating Nr4a1 expression in breast tumors
similarly reported low Nr4a1 expression in higher grade and
metastatic breast tumors (Alexopoulou et al., 2010). In some
cases, studies have shown that aggressive phenotypes of breast
and bladder cancer have low Creb3l1 expression resulting
from Creb3l1 promoter hypermethylation (Rose et al., 2014;
Ward et al., 2016). This is consistent with our findings in
breast cancer cell line Mcf-7 and in N2a cells. Our data
now supports the investigation of both Nr4a1 and Creb3l1 in
cancer studies. The recent development of Nr4a1 agonists that
directly bind and activate Nr4a1 may be useful pharmacological
tools to increase Creb3l1 expression in tumor cells (Cho
et al., 2007; Liu et al., 2010), but our data shows that this
would certainly depend on the methylation status of the
Creb3l1 promoter.
We placed our in vitro findings of Creb3l1 regulation from
our study of AtT20 cells into an in vitro systems context. For
many years, studies have associated the expression of Nr4a1 with
activation of Avp, Ot and corticotropin releasing hormone
transcription in the PVN and SON by cAMP pathways (Chan
et al., 1993; Kawasaki et al., 2005; Girotti et al., 2007). The spatial
pattern of Nr4a1 mRNA distribution in the PVN is dependent on
the nature of the stimulus with restraint stress strongly inducing
Nr4a1 expression in parvocellular divisions of the PVN (Imaki
et al., 1996), while in DH and SL expression is largely detected in
magnocellular divisions of PVN and SON (Chan et al., 1993).
Our data agrees with the previous concept of activation
of Avp transcription in vitro by Nr4a1, but suggests that this
mechanism requires the intermediary step of transcriptional
activation of the Creb3l1 gene to promote Avp transcription.
In addition, our findings from in vitro cell cultures hinted that
methylation could be important in regulating Creb3l1 expression
in different cell-types of the PVN, namely AVP andOTneurones,
particularly as Creb3l1 expression increases exclusively in AVP
neurones by DH (Greenwood et al., 2014). We recently described
altered methylation patterns of the Avp promoter with DH in
the SON and in this study we observed decreased expression
of the demethylating enzyme ten-eleven translocation 2, Tet2,
by DH and SL in support of methylation changes in the
hypothalamus (Greenwood et al., 2016a). Interestingly there
was an absence of methylation marks on this region of the
Creb3l1 promoter in vitro in the PVN. This suggests that the
differences in Creb3l1 expression in AVP and OT neurones in
states of DH is achieved through changes to the transcriptional
complement within these two distinctive cell-types rather than
any alterations to promoter methylation. This is consistent
with the strong up-regulation of Nr4a1 and Creb3l1 in AVP
magnocellular neurones by 3 days of DH in the current
study.
In summary, our data shows that transcription of Creb3l1 is
a primary factor influencing the availability of N-terminal
active Creb3l1, and is thus the rate-limiting step in activating
transcriptional targets of this gene. One of the factors
regulating Creb3l1 expression is the nuclear receptor Nr4a1,
which for many years has been postulated to be one
of the key players in the transcriptional cascade that is
activated in the hypothalamus in conditions of raised plasma
osmolality. We show that the abundance/activity of Nr4a1 is
not the limiting factor in increasing the abundance of
Creb3l1 but that this is dictated by the methylation status
of the Creb3l promoter region in our in vitro studies.
Our experiments have culminated in the identification of
a novel cAMP-Nr4a1-Creb3l1 transcriptional pathway. One
of the outputs of this pathway will be increased Avp
transcription in magnocellular neurones of the hypothalamus
(Figure 8). Taken together, this study provides a novel
mechanism of Creb3l1 activation by Nr4a1 that adds important
understanding to transcriptional mechanisms not only in the
hypothalamus but also possibly more broadly within cancer
research.
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